{"DataElement":{"publicId":"4115951","version":"1","preferredName":"Lynch Syndrome Mutation Test Type","preferredDefinition":"The response identifying the test name(s) or method(s) used to assess a specific marker for Lynch Syndrome that indicates the presence of an autosomal dominant hereditary neoplastic syndrome characterized by the development of colorectal carcinoma and a high risk of developing endometrial carcinoma, gastric carcinoma, ovarian carcinoma, renal pelvis carcinoma, and small intestinal carcinoma.","longName":"LYN_SYN_MUT_TST_TYP","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"4115913","version":"1","preferredName":"Lynch Syndrome Mutation","preferredDefinition":"An autosomal dominant hereditary neoplastic syndrome characterized by the development of colorectal carcinoma and a high risk of developing endometrial carcinoma, gastric carcinoma, ovarian carcinoma, renal pelvis carcinoma, and small intestinal carcinoma. Patients often develop colorectal carcinomas at an early age (mean, 45 years). In the majority of the cases the lesions arise from the proximal colon. At the molecular level, high-frequency microsatellite instability is present._Genetic alterations found in the neoplastic lesions of the animal model. These alterations are not made intentionally.","longName":"4115911v1.0:2437512v1.0","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"4115911","version":"1","preferredName":"Lynch Syndrome","preferredDefinition":"An autosomal dominant hereditary neoplastic syndrome characterized by the development of colorectal carcinoma and a high risk of developing endometrial carcinoma, gastric carcinoma, ovarian carcinoma, renal pelvis carcinoma, and small intestinal carcinoma. Patients often develop colorectal carcinomas at an early age (mean, 45 years). In the majority of the cases the lesions arise from the proximal colon. At the molecular level, high-frequency microsatellite instability is present.","longName":"C8494","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lynch Syndrome","conceptCode":"C8494","definition":"An autosomal dominant hereditary neoplastic syndrome characterized by the development of colorectal carcinoma and a high risk of developing endometrial carcinoma, gastric carcinoma, ovarian carcinoma, renal pelvis carcinoma, and small intestinal carcinoma. Patients often develop colorectal carcinomas at an early age (mean, 45 years). In the majority of the cases the lesions arise from the proximal colon. At the molecular level, high-frequency microsatellite instability is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0F94F33-725B-1B0A-E040-BB89AD436BDE","latestVersionIndicator":"Yes","beginDate":"2014-01-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-27","modifiedBy":"ONEDATA","dateModified":"2014-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2437512","version":"1","preferredName":"Mutation","preferredDefinition":"Genetic alterations found in the neoplastic lesions of the animal model. These alterations are not made intentionally.","longName":"C16885","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutation","conceptCode":"C16885","definition":"Genetic alterations found in the neoplastic lesions of the animal model. These alterations are not made intentionally.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07D00C2C-37C7-1C50-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-12-14","modifiedBy":"ONEDATA","dateModified":"2005-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0F94F33-7269-1B0A-E040-BB89AD436BDE","latestVersionIndicator":"Yes","beginDate":"2014-01-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"DCP. MDA2013-01-02. 01.27.14. GHD","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4115939","version":"1","preferredName":"Lynch Syndrome Mutation Test Type","preferredDefinition":"a test name or method used to assess a specific marker for Lynch Syndrome that indicates presence of cancer or tumor.","longName":"LYN_SYN_MUT_TST_TYP","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"45","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Both","valueDescription":"Both","ValueMeaning":{"publicId":"3689450","version":"1","preferredName":"Both","longName":"3689450","preferredDefinition":"One and the other; relating to or being two in conjunction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Both","conceptCode":"C49636","definition":"One and the other; relating to or being two in conjunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D6333A5E-0775-2814-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2013-02-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F0FA0394-94A9-7189-E040-BB89AD432C15","beginDate":"2014-01-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-27","modifiedBy":"ONEDATA","dateModified":"2014-01-27","deletedIndicator":"No"},{"value":"Microsatellite Instability (MSI)","valueDescription":"Microsatellite Instability Testing","ValueMeaning":{"publicId":"4115940","version":"1","preferredName":"Microsatellite Instability Testing","longName":"4115940","preferredDefinition":"Genomic instability associated with defective DNA mismatch repair in tumors.: A procedure for critical evaluation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microsatellite Instability","conceptCode":"C36318","definition":"Genomic instability associated with the presence of hypermutability in specific genetic marker regions resulting from defective DNA mismatch repair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Testing","conceptCode":"C15336","definition":"A procedure for critical evaluation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FA0394-94B7-7189-E040-BB89AD432C15","latestVersionIndicator":"Yes","beginDate":"2014-01-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F0FA0394-94D0-7189-E040-BB89AD432C15","beginDate":"2014-01-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-27","modifiedBy":"ONEDATA","dateModified":"2014-01-27","deletedIndicator":"No"},{"value":"Immunohistochemistry (IHC)","valueDescription":"IMMUNOHISTOCHEMISTRY (IHC)","ValueMeaning":{"publicId":"2558927","version":"1","preferredName":"IMMUNOHISTOCHEMISTRY (IHC)","longName":"2558927","preferredDefinition":"IMMUNOHISTOCHEMISTRY (IHC)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B33C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F0FA0394-94DA-7189-E040-BB89AD432C15","beginDate":"2002-02-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-27","modifiedBy":"ONEDATA","dateModified":"2014-01-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FA0394-9495-7189-E040-BB89AD432C15","latestVersionIndicator":"Yes","beginDate":"2014-01-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-27","modifiedBy":"MAESKEB","dateModified":"2014-03-07","changeDescription":"DCP. MDA2013-01-012. 01-27-14. ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"4188651","version":"1","longName":"MDA2013-01-02","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If Negative, specify type of","type":"Preferred Question Text","description":"If Negative, specify type of testing","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FA2F3A-B25D-8522-E040-BB89AD432A83","latestVersionIndicator":"Yes","beginDate":"2014-01-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-27","modifiedBy":"MAESKEB","dateModified":"2014-03-07","changeDescription":"DCP. MDA2013-01-02_01.27.14_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}